USE OF 1-[4-BROMO-5-[1-ETHYL-7-(METHYLAMINO)-2-OXO-1,2-DIHYDRO-1,6-NAPHTHYRIDINE-3-YL]-2-FLUOROPHENYL]-3-PHENYLURED AND ITS ANALOGUES FOR THE TREATMENT OF CANCERS ASSOCIATED WITH GENETIC ABNORMALITIES IN THE ALPHA RECEPTOR
MA48712AUndetermined Publication Date: 2020-04-08DECIPHERA PHARMACEUTICALS LLC
0 Cites 0 Cited by
Patent Information
- Application Number
- MA48712
- Authority / Receiving Office
- MA · MA
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2017-05-30
- Publication Date
- 2020-04-08
Need to check novelty before this filing date? Find Prior Art
No text content released.